FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2943493063> ?p ?o ?g. }

• W2943493063 endingPage "174480691985004" @default.
• W2943493063 startingPage "174480691985004" @default.
• W2943493063 abstract "Chemotherapy-induced painful peripheral neuropathy is a significant clinical problem that is associated with widely used chemotherapeutics. Unfortunately, the molecular mechanisms by which chemotherapy-induced painful peripheral neuropathy develops have remained elusive. The proteasome inhibitor, bortezomib, has been shown to induce aerobic glycolysis in sensory neurons. This altered metabolic phenotype leads to the extrusion of metabolites which sensitize primary afferents and cause pain. Hypoxia-inducible factor alpha is a transcription factor that is known to reprogram cellular metabolism. Furthermore, hypoxia-inducible factor 1 alpha protein is constantly synthesized and undergoes proteasomal degradation in normal conditions. However, metabolic stress or hypoxia stabilizes the expression of hypoxia-inducible factor 1 alpha leading to the transcription of genes that reprogram cellular metabolism. This study demonstrates that treatment of mice with bortezomib stabilizes the expression of hypoxia-inducible factor 1 alpha. Moreover, knockdown of hypoxia-inducible factor 1 alpha, inhibition of hypoxia-inducible factor 1 alpha binding to its response element, or limiting its translation by using metformin prevent the development of bortezomib-induced neuropathic pain. Strikingly, the blockade of hypoxia-inducible factor 1 alpha expression does not attenuate mechanical allodynia in mice with existing bortezomib-induced neuropathic pain. These results establish the stabilization of hypoxia-inducible factor 1 alpha expression as the molecular mechanism by which bortezomib initiates chemotherapy-induced painful peripheral neuropathy. Crucially, these findings reveal that the initiation and maintenance of bortezomib-induced neuropathic pain are regulated by distinct mechanisms." @default.
• W2943493063 created "2019-05-09" @default.
• W2943493063 creator A5015332586 @default.
• W2943493063 creator A5039184833 @default.
• W2943493063 date "2019-01-01" @default.
• W2943493063 modified "2023-09-25" @default.
• W2943493063 title "Bortezomib and metformin opposingly regulate the expression of hypoxia-inducible factor alpha and the consequent development of chemotherapy-induced painful peripheral neuropathy" @default.
• W2943493063 cites W105474233 @default.
• W2943493063 cites W1523693806 @default.
• W2943493063 cites W1713016576 @default.
• W2943493063 cites W1876548041 @default.
• W2943493063 cites W1964229131 @default.
• W2943493063 cites W1966371053 @default.
• W2943493063 cites W1972346852 @default.
• W2943493063 cites W1974049018 @default.
• W2943493063 cites W1977924327 @default.
• W2943493063 cites W1978763812 @default.
• W2943493063 cites W1982219839 @default.
• W2943493063 cites W1985458442 @default.
• W2943493063 cites W1987155536 @default.
• W2943493063 cites W1990116234 @default.
• W2943493063 cites W1995300665 @default.
• W2943493063 cites W2021983664 @default.
• W2943493063 cites W2022451432 @default.
• W2943493063 cites W2025968906 @default.
• W2943493063 cites W2027889563 @default.
• W2943493063 cites W2033958147 @default.
• W2943493063 cites W2034667463 @default.
• W2943493063 cites W2035266548 @default.
• W2943493063 cites W2035286495 @default.
• W2943493063 cites W2039559587 @default.
• W2943493063 cites W2040031153 @default.
• W2943493063 cites W2041403839 @default.
• W2943493063 cites W2042216712 @default.
• W2943493063 cites W2050140657 @default.
• W2943493063 cites W2051118171 @default.
• W2943493063 cites W2053242178 @default.
• W2943493063 cites W2063231976 @default.
• W2943493063 cites W2063315207 @default.
• W2943493063 cites W2067500495 @default.
• W2943493063 cites W2068734526 @default.
• W2943493063 cites W2074599258 @default.
• W2943493063 cites W2087214757 @default.
• W2943493063 cites W2090817847 @default.
• W2943493063 cites W2096318291 @default.
• W2943493063 cites W2098134455 @default.
• W2943493063 cites W2098628437 @default.
• W2943493063 cites W2102891343 @default.
• W2943493063 cites W2107936815 @default.
• W2943493063 cites W2109655788 @default.
• W2943493063 cites W2120129511 @default.
• W2943493063 cites W2127584960 @default.
• W2943493063 cites W2131681881 @default.
• W2943493063 cites W2138077682 @default.
• W2943493063 cites W2142786915 @default.
• W2943493063 cites W2144625075 @default.
• W2943493063 cites W2153607816 @default.
• W2943493063 cites W2167479466 @default.
• W2943493063 cites W2172201406 @default.
• W2943493063 cites W2194931157 @default.
• W2943493063 cites W2262413988 @default.
• W2943493063 cites W2344746583 @default.
• W2943493063 cites W2415515169 @default.
• W2943493063 cites W2589026565 @default.
• W2943493063 cites W2594969100 @default.
• W2943493063 cites W2603102282 @default.
• W2943493063 cites W2611191186 @default.
• W2943493063 cites W2622681669 @default.
• W2943493063 cites W2726806619 @default.
• W2943493063 cites W2767172151 @default.
• W2943493063 cites W2917680098 @default.
• W2943493063 doi "https://doi.org/10.1177/1744806919850043" @default.
• W2943493063 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6509977" @default.
• W2943493063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31041875" @default.
• W2943493063 hasPublicationYear "2019" @default.
• W2943493063 type Work @default.
• W2943493063 sameAs 2943493063 @default.
• W2943493063 citedByCount "18" @default.
• W2943493063 countsByYear W29434930632019 @default.
• W2943493063 countsByYear W29434930632020 @default.
• W2943493063 countsByYear W29434930632021 @default.
• W2943493063 countsByYear W29434930632022 @default.
• W2943493063 countsByYear W29434930632023 @default.
• W2943493063 crossrefType "journal-article" @default.
• W2943493063 hasAuthorship W2943493063A5015332586 @default.
• W2943493063 hasAuthorship W2943493063A5039184833 @default.
• W2943493063 hasBestOaLocation W29434930631 @default.
• W2943493063 hasConcept C104317684 @default.
• W2943493063 hasConcept C126322002 @default.
• W2943493063 hasConcept C134018914 @default.
• W2943493063 hasConcept C160450060 @default.
• W2943493063 hasConcept C178790620 @default.
• W2943493063 hasConcept C185592680 @default.
• W2943493063 hasConcept C2776364478 @default.
• W2943493063 hasConcept C2777107010 @default.
• W2943493063 hasConcept C2777478702 @default.
• W2943493063 hasConcept C2778367456 @default.
• W2943493063 hasConcept C2779901536 @default.

• next